Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

4Total

Not Applicable (4)

Trial Status

Unknown2

Recruiting1

Completed1

Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (5)

Showing 5 of 5 trials

NCT02933489Not ApplicableActive Not RecruitingPrimary

Abbreviated Breast MRI and Digital Tomosynthesis Mammography in Screening Women With Dense Breasts

NCT05884840Not ApplicableRecruiting

New Cardiovascular Risk Screening Strategy.

NCT04388280Not ApplicableUnknownPrimary

Imaging vs. no Testing in Asymptomatic High-risk Diabetic Patients

NCT00497094Not ApplicableCompletedPrimary

Stenting Versus Best Medical Treatment of Asymptomatic High Grade Carotid Artery Stenosis

NCT00847353Unknown

Normal Values of High Frequency ECG (HyperQ™) in Apparently Healthy Individuals and in Young and Masters Athletes

Showing all 5 trials

Asymptomatic